Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Major Shareholding Notification 2008

Oct 29, 2008

31210_mrq_2008-10-29_069d07ca-333f-44f0-9f26-5ec55bfd50b8.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SC 13D/A 1 g16302a3sc13dza.htm ARGAN, INC. - FORM SC 13D/A RICHARD L. SCOTT ARGAN, INC. - FORM SC 13D/A RICHARD L. SCOTT PAGEBREAK

OMB APPROVAL
OMB Number: 3235-0145
Expires: February 28, 2009
Estimated average burden hours per response...14.5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

Under the Securities Exchange Act of 1934 (Amendment No. 3 )*

Argan, Inc.

(Name of Issuer)

Common Stock, $.15 par value

(Title of Class of Securities)

746375107

(CUSIP Number)

Jeffrey S. Buschman, Esq. Boult Cummings Conners & Berry, PLC 1600 Division Street, Suite 700 Nashville, Tennessee 37203 (615) 252-2388

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

October 8, 2008

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

  • The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

PAGEBREAK

CUSIP No. 746375107 SCHEDULE 13D

1 NAMES OF REPORTING PERSONS Richard L. Scott
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
o
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
7 SOLE VOTING POWER
NUMBER OF 1,950,000
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY -0-
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 1,950,000
WITH 10 SHARED DISPOSITIVE POWER
-0-
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,950,000
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.5%
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN

Folio 2 /Folio PAGEBREAK

This Amendment No. 3 amends the Schedule 13D filed by Richard L. Scott (“Reporting Person”) on December 18, 2006 (the “Schedule 13D”), as amended June 8, 2007 and November 7, 2007, with respect to shares of the Common Stock, $.15 par value (“Common Stock”), of Argan, Inc., a Delaware corporation (the “Issuer”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Schedule 13D.

The following Items are hereby amended and restated in their entirety to read as follows:

ITEM 3. Source and Amount of Funds or Other Consideration

The Reporting Person has used personal funds of approximately $9,925,000 to acquire 1,750,000 shares of Common Stock and options to purchase 200,000 shares of Common Stock (the “Options”) in private transactions. The Common Stock and the Options were purchased by a limited liability company controlled by the Reporting Person.

ITEM 5. Interest in Securities of the Issuer

The 1,750,000 shares of the Common Stock and the Options to purchase an additional 200,000 shares of Common Stock owned by the Reporting Person constitute 14.5% of the outstanding Common Stock of the Issuer.

The Reporting Person has sole voting and dispositive power with respect to the Common Stock.

The Reporting Person exercised options to acquire the following shares of the Common Stock of the Issuer in a private transaction:

Purchase Date No. of Shares Price Per Share Aggregate — Consideration
10/8/2008 100,000 $12.50 $1,250,000
10/14/2008 100,000 $12.50 $1,250,000

The Common Stock was purchased by Argan Investments, LLC, a member managed limited liability company of which Reporting Person is the controlling member.

The Reporting Person has not purchased or sold any other shares of Common Stock of the Issuer during the past 60 days.

Folio 3 /Folio

PAGEBREAK

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

DATED: October 29, 2008
Richard L. Scott

Folio 4 /Folio